Empagliflozin is an inhibitor of SGLT2, the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation
The emerging research: what scientists are studying now The relationship between GLP-1 therapy and urinary health is an active area of investigation, and several research threads deserve attention
Non-Hormonal Option : Unlike hormone-based therapies, Bremelanotide works through the central nervous system, making it suitable for individuals who want a non-hormonal approach to enhancing sexual wellness
Semaglutide specifically enhances insulin sensitivity, which helps regulate the genes responsible for cholesterol synthesis

As Colorado has state-supervised, county-administered benefits assistance, we are collaborating with the Colorado Department of Human Services and counties to improve eligibility and application processes: Improving our systems that support members, applicants and eligibility workers including improvements to PEAK, the online member-facing portal for applications and renewals, and improvements to the back end system that eligibility workers use called the Colorado Benefits Management System (CBMS) Streamlining and standardizing eligibility processes to increase quality and consistency for service across counties through Joint Agency Interoperability Exploring policies and a new funding model for county administration as authorized by County Administration of Public Assistance Programs (SB22-235) We are updating our member correspondence to improve clarity, and continuing to increase renewal automation (ex parte) and digital renewal (PEAK) capabilities

Alterations and fluctuations in gut microbiota and its metabolites appear to promote development and maintenance of IBS symptoms